219 related articles for article (PubMed ID: 19729298)
21. A genetic study of the role of the Wnt/beta-catenin signalling in Paneth cell differentiation.
Andreu P; Peignon G; Slomianny C; Taketo MM; Colnot S; Robine S; Lamarque D; Laurent-Puig P; Perret C; Romagnolo B
Dev Biol; 2008 Dec; 324(2):288-96. PubMed ID: 18948094
[TBL] [Abstract][Full Text] [Related]
22. Genomic response to Wnt signalling is highly context-dependent--evidence from DNA microarray and chromatin immunoprecipitation screens of Wnt/TCF targets.
Railo A; Pajunen A; Itäranta P; Naillat F; Vuoristo J; Kilpeläinen P; Vainio S
Exp Cell Res; 2009 Oct; 315(16):2690-704. PubMed ID: 19563800
[TBL] [Abstract][Full Text] [Related]
23. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
24. Mapping canonical Wnt signaling in the developing and adult retina.
Liu H; Thurig S; Mohamed O; Dufort D; Wallace VA
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5088-97. PubMed ID: 17065530
[TBL] [Abstract][Full Text] [Related]
25. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation.
Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER
Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755
[TBL] [Abstract][Full Text] [Related]
26. Wnt signaling and cancer development: therapeutic implication.
Paul S; Dey A
Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648
[TBL] [Abstract][Full Text] [Related]
27. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
[TBL] [Abstract][Full Text] [Related]
28. Conditional mutations of beta-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation.
Martinez G; Wijesinghe M; Turner K; Abud HE; Taketo MM; Noda T; Robinson ML; de Iongh RU
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4794-806. PubMed ID: 19515997
[TBL] [Abstract][Full Text] [Related]
29. Hypermethylation of APC promoter 1A is associated with moderate activation of Wnt signalling pathway in a subset of colorectal serrated adenomas.
Fu X; Li J; Li K; Tian X; Zhang Y
Histopathology; 2009 Nov; 55(5):554-63. PubMed ID: 19912361
[TBL] [Abstract][Full Text] [Related]
30. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
Takahashi M; Nakamura Y; Obama K; Furukawa Y
Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
[TBL] [Abstract][Full Text] [Related]
31. Negative regulation of the Wnt signal by MM-1 through inhibiting expression of the wnt4 gene.
Yoshida T; Kitaura H; Hagio Y; Sato T; Iguchi-Ariga SM; Ariga H
Exp Cell Res; 2008 Apr; 314(6):1217-28. PubMed ID: 18281035
[TBL] [Abstract][Full Text] [Related]
32. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
Chen RH; McCormick F
Cancer Res; 2001 Jun; 61(11):4445-9. PubMed ID: 11389074
[TBL] [Abstract][Full Text] [Related]
33. Gene therapy approach in prostate cancer cells using an active Wnt signal.
Giladi N; Dvory-Sobol H; Sagiv E; Kazanov D; Liberman E; Arber N
Biomed Pharmacother; 2007 Oct; 61(9):527-30. PubMed ID: 17904788
[TBL] [Abstract][Full Text] [Related]
34. Anticancer activity of Panax notoginseng extract 20(S)-25-OCH3-PPD: Targetting beta-catenin signalling.
Bi X; Zhao Y; Fang W; Yang W
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1074-8. PubMed ID: 19413587
[TBL] [Abstract][Full Text] [Related]
35. Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling.
Hölsken A; Buchfelder M; Fahlbusch R; Blümcke I; Buslei R
Acta Neuropathol; 2010 May; 119(5):631-9. PubMed ID: 20131060
[TBL] [Abstract][Full Text] [Related]
36. Active Wnt signalling is associated with low differentiation and high proliferation in human biliary tract cancer in vitro and in vivo and is sensitive to pharmacological inhibition.
Kiesslich T; Alinger B; Wolkersdörfer GW; Ocker M; Neureiter D; Berr F
Int J Oncol; 2010 Jan; 36(1):49-58. PubMed ID: 19956832
[TBL] [Abstract][Full Text] [Related]
37. Phospholipase D meets Wnt signaling: a new target for cancer therapy.
Kang DW; Choi KY; Min do S
Cancer Res; 2011 Jan; 71(2):293-7. PubMed ID: 21224347
[TBL] [Abstract][Full Text] [Related]
38. Wnt signaling as a therapeutic target for cancer.
Herbst A; Kolligs FT
Methods Mol Biol; 2007; 361():63-91. PubMed ID: 17172707
[TBL] [Abstract][Full Text] [Related]
39. Beta-catenin/LEF1 activated enamelin expression in ameloblast-like cells.
Tian H; Lv P; Ma K; Zhou C; Gao X
Biochem Biophys Res Commun; 2010 Jul; 398(3):519-24. PubMed ID: 20599763
[TBL] [Abstract][Full Text] [Related]
40. Wnt activation and alternative promoter repression of LEF1 in colon cancer.
Li TW; Ting JH; Yokoyama NN; Bernstein A; van de Wetering M; Waterman ML
Mol Cell Biol; 2006 Jul; 26(14):5284-99. PubMed ID: 16809766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
